Premium
Citalopram is a more potent platelet function inhibitor than paroxetine in a case–control study
Author(s) -
VAN HOLTEN T. C.,
ROEST M.,
RIPHAGEN J.,
JANSEN C.,
NAARDING P.,
ADRIAANSEN H. J.,
DE GROOT P. G.,
REMIJN J. A.
Publication year - 2012
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2012.04703.x
Subject(s) - paroxetine , platelet , citalopram , serotonin , platelet activation , medicine , pharmacology , reuptake inhibitor , receptor